YK-2-69

CAS No. 2619846-89-6

YK-2-69( —— )

Catalog No. M36287 CAS No. 2619846-89-6

YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 686 In Stock
10MG 938 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    YK-2-69
  • Note
    Research use only, not for human use.
  • Brief Description
    YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.
  • Description
    YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    DYRK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2619846-89-6
  • Formula Weight
    506.6
  • Molecular Formula
    C25H27FN8OS
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(C1=CN=C(C=C1)NC=2N=CC(F)=C(N2)C=3C=CC=4N=C(SC4C3)N(C)C)N5CCN(CC)CC5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Bonaid TM

    (E)-[6]-Dehydroparadol shows growth inhibition and induction of apoptosis against human cancer cells(IC50 values of 43.02 μM in HCT-116 cell and 41.59 μM in H-1299 cell, respectively).

  • N-Boc-4-pentyne-1-am...

    N-Boc-4-pentyne-1-amine is a PROTAC linker, which refers to the alkyl chain composition. N-Boc-4-pentyne-1-amine can be used in the synthesis of the PROTAC MG-277.

  • Difopein TFA

    Difopein (TFA), a specific and competitive inhibitor of 14-3-3 protein (a highly conserved eukaryotic regulatory molecule), blocking the ability of 14-3-3 to bind to target proteins and inhibits 14-3-3/Ligand interactions. Difopein (TFA) leads to induction of apoptosis and enhances the ability of cisplatin to kill cells.